Mild systemic oxidative stress in the subclinical stage of Alzheimer's disease

Oxidative Medicine and Cellular Longevity

Volumn , Issue , 2013, Pages

  Giavarotti, Leandro ^a   Simon, Karin A ^b   Azzalis, Ligia A ^b   Fonseca, Fernando L A ^b   Lima, Alessandra F ^b,c   Freitas, Maria C V ^b   Brunialti, Milena K C ^b   Salomão, Reinaldo ^b   Moscardi, Alcione A V S ^b   M Montaño, Maria B M ^b   Ramos, Luiz R ^b   Junqueira, Virgínia B C ^b  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^c FACULDADE DE MEDICINA DO ABC   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIOXIDANT; CYTOKINE;

AGED; ALZHEIMER DISEASE; ARTICLE; BLOOD; ENZYMOLOGY; ERYTHROCYTE; FLOW CYTOMETRY; HUMAN; METABOLISM; MONOCYTE; OXIDATION REDUCTION REACTION; OXIDATIVE STRESS; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ALZHEIMER DISEASE; ANTIOXIDANTS; CYTOKINES; ERYTHROCYTES; FLOW CYTOMETRY; HUMANS; MONOCYTES; OXIDATION-REDUCTION; OXIDATIVE STRESS;

EID: 84893866819     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2013/609019     Document Type: Article

References (36)

1. Dickerson B. C., Bakkour A., Salat D. H., Feczko E., Pacheco J., Greve D. N., Grodstein F., Wright C. I., Blacker D., Rosas H. D., Sperling R. A., Atri A., Growdon J. H., Hyman B. T., Morris J. C., Fischl B., Buckner R. L., The cortical signature of Alzheimer's disease: regionally specific cortical thinning relates to symptom severity in very mild to mild AD dementia and is detectable in asymptomatic amyloid-positive individuals. Cerebral Cortex 2009 19 3 497 510 2-s2.0-59749096829 10.1093/cercor/bhn113
2. Jana A., Pahan K., Fibrillar amyloid- β peptides kill human primary neurons via NADPH oxidase-mediated activation of neutral sphingomyelinase: Implications for Alzheimer's disease. Journal of (Pubitemid 40017893)
3. Finch C. E., Morgan T. E., Inflammatory processes of Alzheimer disease and aging. Proceedings of the Indian National Science Academy B 2003 69 165 178
4. Zotova E., Nicoll J. A., Kalaria R., Holmes C., Boche D., Inflammation in Alzheimer's disease: relevance to pathogenesis and therapy. Alzheimer's Research and Therapy 2010 2 1, article 1 2-s2.0-77953143687 10.1186/alzrt24
5. Rojo L. E., Fernández J. A., Maccioni A. A., Jimenez J. M., Maccioni R. B., Neuroinflammation: implications for the pathogenesis and molecular diagnosis of Alzheimer's disease. Archives of Medical Research 2008 39 1 1 16 2-s2.0-36549083642 10.1016/j.arcmed.2007.10.001 (Pubitemid 350192021)
6. Jomova K., Vondrakova D., Lawson M., Valko M., Metals, oxidative stress and neurodegenerative disorders. Molecular and Cellular Biochemistry 2010 345 1-2 91 104 2-s2.0-78449282609 10.1007/s11010-010-0563-x
7. Junqueira V. B. C., Barros S. B. M., Chan S. S., Rodrigues L., Giavarotti L., Abud R. L., Deucher G. P., Aging and oxidative stress. Molecular Aspects of Medicine 2004 25 1-2 5 16 2-s2.0-1642422781 10.1016/j.mam.2004.02.003 (Pubitemid 38401927)
8. Folstein M. F., Folstein S. E., McHugh P. R., Mini-mental state A practical method for grading the cognitive state of patients for the clinician. Journal of Psychiatric Research 1975 12 3 189 198 10.1016/0022-3956(75)90026-6
9. Morris J. C., The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology 1993 43 11 2412 2414 2-s2.0-0027425211 (Pubitemid 23346995)
10. Montaño M. B. M., Ramos L. R., Validity of the Portuguese version of Clinical Dementia Rating. Revista de Saúde Pública 2005 39 6 912 917
11. Tietze F., Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. Analytical Biochemistry 1969 27 3 502 522 2-s2.0-0014481378
12. Buss H., Chan T. P., Sluis K. B., Domigan N. B., Winterbourn C. C., Protein carbonyl measurement by a sensitive ELISA method. Free Radical Biology and Medicine 1998 23 3 361 366 10.1016/S0891-5849(97)00104-4
13. Brunialti M. K. C., Kallás E. G., Freudenberg M., Galanos C., Salomão R., Influence of EDTA and heparin on lipopolysaccharide binding and cell activation, evaluated at single-cell level in whole blood. Clinical Cytometry 2002 50 1 14 18 2-s2.0-0037085337 10.1002/cyto.10049 (Pubitemid 37509476)
14. Hasui M., Hirabayashi Y., Kobayashi Y., Simultaneous measurement by flow cytometry of phagocytosis and hydrogen peroxide production of neutrophils in whole blood. Journal of Immunological Methods 1989 117 1 53 58 2-s2.0-0024541441 10.1016/0022-1759(89)90118-X (Pubitemid 19038718)
15. Wegiel J., Imaki H., Wang K.-C., Wegiel J., Wronska A., Osuchowski M., Rubenstein R., Origin and turnover of microglial cells in fibrillar plaques of APPsw transgenic mice. Acta Neuropathologica 2003 105 4 393 402 2-s2.0-0038790267 (Pubitemid 36798833)
16. D'Andrea M. R., Cole G. M., Ard M. D., The microglial phagocytic role with specific plaque types in the Alzheimer disease brain. Neurobiology of Aging 2004 25 5 675 683 2-s2.0-2542431100 10.1016/j.neurobiolaging.2003.12.026 (Pubitemid 38686491)
17. Viña J., Lloret A., Ortí R., Alonso D., Molecular bases of the treatment of Alzheimer's disease with antioxidants: prevention of oxidative stress. Molecular Aspects of Medicine 2004 25 1-2 117 123 2-s2.0-1642463824 10.1016/j.mam.2004.02.013 (Pubitemid 38401936)
18. Polidori M. C., Mattioli P., Aldred S., Cecchetti R., Stahl W., Griffiths H., Senin U., Sies H., Mecocci P., Plasma antioxidant status, immunoglobulin G oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia. Dementia and Geriatric Cognitive Disorders 2004 18 3-4 265 270 2-s2.0-5644239560 10.1159/000080027 (Pubitemid 39370302)
19. Conrad C. C., Marshall P. L., Talent J. M., Malakowsky C. A., Choi J., Gracy R. W., Oxidized proteins in Alzheimer's plasma. Biochemical and Biophysical Research Communications 2000 275 2 678 681 2-s2.0-0034726753 10.1006/bbrc.2000.3356
20. Choi J., Malakowsky C. A., Talent J. M., Conrad C. C., Gracy R. W., Identification of oxidized plasma proteins in Alzheimer's disease. Biochemical and Biophysical Research Communications 2002 293 5 1566 1570 2-s2.0-0036079419 10.1016/S0006-291X(02)00420-5 (Pubitemid 34681057)
21. Heseker H., Schneider R., Requirement and supply of vitamin C, E and β -carotene for elderly men and women. European Journal of Clinical Nutrition 1994 48 2 118 127 2-s2.0-0028012098 (Pubitemid 24063151)
22. Stocker R., Frei B., Sies H., Endogenous antioxidant defences in human blood plasma. Oxidative Stress: Oxidants and Antioxidants 1991 London, UK Academic Press
23. Gey K. F., Rice-Evans C., Prevention of early stages of cardiovascular disease and cancer may require concurrent optimization of all major antioxidants and other nutrients, an update and reevaluation of observational data and intervention trials. Free Radicals, Lipoprotein Oxidation and Atherosclerosis 1995 London, UK Richelieu Press
24. Behl C., Moosmann B., Antioxidant neuroprotection in Alzheimer's disease as preventive and therapeutic approach. Free Radical Biology and Medicine 2002 33 2 182 191 2-s2.0-0037098866 10.1016/S0891-5849(02)00883-3 (Pubitemid 34775190)
25. Esposito E., Rotilio D., di Matteo V., di Giulio C., Cacchio M., Algeri S., A review of specific dietary antioxidants and the effects on biochemical mechanisms related to neurodegenerative processes. Neurobiology of Aging 2002 23 5 719 735 2-s2.0-0036751978 10.1016/S0197-4580(02)00078-7 (Pubitemid 35217698)
26. Mecocci P., Cristina Polidori M., Cherubini A., Ingegni T., Mattioli P., Catani M., Rinaldi P., Cecchetti R., Stahl W., Senin U., Flint Beal M., Lymphocyte oxidative DNA damage and plasma antioxidants in Alzheimer disease. Archives of Neurology 2002 59 5 794 798 2-s2.0-0036094092 (Pubitemid 34517762)
27. Sano M., Do dietary antioxidants prevent Alzheimer's disease? The Lancet Neurology 2002 1 6 342 2-s2.0-0043013401 (Pubitemid 37159158)
28. Chan S. S., Monteiro H. P., Schindler F., Stern A., Junqueira V. B. C., α -tocopherol modulates tyrosine phosphorylation in human neutrophils by inhibition of protein kinas C activity and activation of tyrosine phosphatases. Free Radical Research 2001 35 6 843 856 2-s2.0-0035695424 (Pubitemid 34065673)
29. Bulger E. M., Maier R. V., An argument for vitamin E supplementation in the management of systemic inflammatory response syndrome. Shock 2003 19 2 99 103 2-s2.0-0041808751
30. Zandi P. P., Anthony J. C., Khachaturian A. S., Stone S. V., Gustafson D., Tschanz J. T., Norton M. C., Welsh-Bohmer K. A., Breitner J. C. S., Reduced risk of Alzheimer disease in users of antioxidant vitamin supplements: the Cache County study. Archives of Neurology 2004 61 1 82 88 2-s2.0-0346688728 10.1001/archneur.61.1.82 (Pubitemid 38067418)
31. Kusdra L., Rempel H., Yaffe K., Pulliam L., Elevation of CD69+ monocyte/macrophages in patients with Alzheimer's disease. Immunobiology 2000 202 1 26 33 2-s2.0-0034074287 (Pubitemid 30323613)
32. Casal J. A., Robles A., Tutor J. C., Serum markers of monocyte/macrophage activation in patients with Alzheimer's disease and other types of dementia. Clinical Biochemistry 2003 36 7 553 556 2-s2.0-0141918828 10.1016/S0009-9120(03) 00093-6 (Pubitemid 37244018)
33. Combs C. K., Colleen Karlo J., Kao S.-C., Landreth G. E., β -amyloid stimulation of microglia anti monocytes results in TNF α -dependent expression of inducible nitric oxide synthase and neuronal apoptosis. Journal of Neuroscience 2001 21 4 1179 1188 2-s2.0-0035866060 (Pubitemid 32128763)
34. Beloosesky Y., Salman H., Bergman M., Bessler H., Djaldetti M., Cytokine levels and phagocytic activity in patients with Alzheimer's disease. Gerontology 2002 48 3 128 132 2-s2.0-0036229777 10.1159/000052830 (Pubitemid 34310066)
35. Shalit F., Sredni B., Stern L., Kott E., Huberman M., Elevated interleukin-6 secretion levels by mononuclear cells of Alzheimer's patients. Neuroscience Letters 1994 174 2 130 132 2-s2.0-0028341702 10.1016/0304-3940(94) 90003-5 (Pubitemid 24199480)
36. Azzi A., Gysin R., Kempná P., Ricciarelli R., Villacorta L., Visarius T., Zingg J.-M., The role of α -tocopherol in preventing disease: from epidemiology to molecular events. Molecular Aspects of Medicine 2003 24 6 325 336 2-s2.0-0142185250 10.1016/S0098-2997(03)00028-1 (Pubitemid 37324645)